Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if adjusting the dose of lopinavir/ritonavir (LPV/r) has
a better effect on lowering HIV viral load (the amount of HIV in the blood) compared to
taking the standard FDA-approved LPV/r dose. This study will also compare the safety and
tolerability of these two types of dosing.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)